| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |